Odoma V, Pitliya A, AlEdani E, Bhangu J, Javed K, Manshahia P
Cureus. 2023; 15(9):e45485.
PMID: 37727840
PMC: 10506738.
DOI: 10.7759/cureus.45485.
Nakatani T, Shiosakai K, Hashimoto T, Shionoya M, Akasaka T, Toyama K
J Palliat Med. 2022; 26(6):768-775.
PMID: 36579915
PMC: 10278029.
DOI: 10.1089/jpm.2022.0289.
Rodieux F, Ivanyuk A, Besson M, Desmeules J, Samer C
Front Pediatr. 2022; 10:842454.
PMID: 35547539
PMC: 9083226.
DOI: 10.3389/fped.2022.842454.
Coluzzi F, Caputi F, Billeci D, Pastore A, Candeletti S, Rocco M
Ther Clin Risk Manag. 2020; 16:821-837.
PMID: 32982255
PMC: 7490082.
DOI: 10.2147/TCRM.S262843.
Reis A, Luecke C, Davis T, Kakajiwala A
J Pediatr Pharmacol Ther. 2018; 23(3):192-202.
PMID: 29970975
PMC: 6027978.
DOI: 10.5863/1551-6776-23.3.192.
Mitigating the risk of opioid abuse through a balanced undergraduate pain medicine curriculum.
Morley-Forster P, Pergolizzi J, Taylor Jr R, Axford-Gatley R, Sellers E
J Pain Res. 2013; 6:791-801.
PMID: 24353438
PMC: 3862507.
DOI: 10.2147/JPR.S47192.
Options for treating postherpetic neuralgia in the medically complicated patient.
Bruckenthal P, Barkin R
Ther Clin Risk Manag. 2013; 9:329-40.
PMID: 23990726
PMC: 3753169.
DOI: 10.2147/TCRM.S47138.
Update on prescription extended-release opioids and appropriate patient selection.
Brennan M
J Multidiscip Healthc. 2013; 6:265-80.
PMID: 23900563
PMC: 3726523.
DOI: 10.2147/JMDH.S38562.
Analgesics in patients with hepatic impairment: pharmacology and clinical implications.
Bosilkovska M, Walder B, Besson M, Daali Y, Desmeules J
Drugs. 2012; 72(12):1645-69.
PMID: 22867045
DOI: 10.2165/11635500-000000000-00000.
Recent advances in the use of opioids for cancer pain.
Droney J, Riley J
J Pain Res. 2011; 2:135-55.
PMID: 21197301
PMC: 3004622.
DOI: 10.2147/jpr.s6905.
Implications of opioid analgesia for medically complicated patients.
Smith H, Bruckenthal P
Drugs Aging. 2010; 27(5):417-33.
PMID: 20450239
DOI: 10.2165/11536540-000000000-00000.
Opioid metabolism.
Smith H
Mayo Clin Proc. 2009; 84(7):613-24.
PMID: 19567715
PMC: 2704133.
DOI: 10.1016/S0025-6196(11)60750-7.
Effect of hydromorphone on ventilation in palliative care patients with dyspnea.
Clemens K, Klaschik E
Support Care Cancer. 2007; 16(1):93-9.
PMID: 17929063
DOI: 10.1007/s00520-007-0310-3.
Pain in terminally ill patients: guidelines for pharmacological management.
Thomas J, von Gunten C
CNS Drugs. 2003; 17(9):621-31.
PMID: 12828498
DOI: 10.2165/00023210-200317090-00002.
Demographics, assessment and management of pain in the elderly.
Davis M, Srivastava M
Drugs Aging. 2003; 20(1):23-57.
PMID: 12513114
DOI: 10.2165/00002512-200320010-00003.
Pharmacokinetics and pharmacodynamics of sedatives and analgesics in the treatment of agitated critically ill patients.
Wagner B, OHara D
Clin Pharmacokinet. 1998; 33(6):426-53.
PMID: 9435992
DOI: 10.2165/00003088-199733060-00003.
